Justin Scot Hanes

This inventor holds 71 USPTO granted patents and 42 published patent applications, plus 12 CIPO patents and 14 EPO patents, primarily in Nanoparticle Drug Delivery (CPC class A61K). Top assignees: Johns Hopkins University, The Penn State Research Foundation, Massachusetts Institute of Technology. Active years: 1999-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Justin Scot Hanes. Retrieved from https://idiyas.com/inventor/justin-scot-hanes

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 71 (Patent Applications = 42)

% Patents Active = 93.0

CIPO Patents = 12

EPO Patents = 14 (Patent Applications = 23)

Average Co-Inventor Count = 4.5

ph-index = 18

Forward Citations = 2,320(Granted Patents)

Forward Citations (Not Self Cited) = 2,111(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

52 out of 3,803

Johns Hopkins University

patents

8 out of 1,341

The Penn State Research Foundation

patents

7 out of 8,594

Massachusetts Institute of Technology

patents

4. 5 out of 53

Kala Pharmaceuticals, Inc.

patents

5. 1 out of 14

Spiral Therapeutics, Inc.

patents

6. 1 out of 2,029

University System of Maryland

patents

7. 6 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 1999-2025

Loading Chart...

Areas of Expertise:

Nanoparticles

Drug Delivery

Mucus Penetration

Gene Vectors

Sunitinib

Biodegradable Platforms

Therapeutic Agents

Microbicidal Formulations

Nanocrystals

Ophthalmic Applications

Targeted Delivery

Polymeric Nanoparticles

71 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12496279 - Nanoparticles for drug delivery to brain (2025-12-16),

2. 12178920 - Nanocrystals, compositions, and methods that aid particle transport in mucus (2024-12-31),

3. 12156942 - Sustained delivery of therapeutic agents to an eye compartment (2024-12-03),

4. 12005089 - CVS transplantation for treatment of bacterial vaginosis (2024-06-11),

5. 11872318 - Nanocrystals, compositions, and methods that aid particle transport in mucus (2024-01-16),

6. 11660349 - Non-linear multiblock copolymer-drug conjugates for the delivery of active agents (2023-05-30),

7. 11642317 - Nanocrystals, compositions, and methods that aid particle transport in mucus (2023-05-09),

8. 11633350 - Hypotonic microbicidal formulations and methods of use (2023-04-25),

9. 11426345 - Hypotonic hydrogel formulations for enhanced transport of active agents at mucosal surfaces (2022-08-30),

10. 11090391 - Protein nanocages with enhanced mucus penetration for targeted tissue and intracellular delivery (2021-08-17),

11. 11033637 - Targeted structure-specific particulate delivery systems (2021-06-15),

12. 11013719 - Sunitinib formulations and methods for use thereof in treatment of glaucoma (2021-05-25),

13. 11007297 - Process for making aligned or twisted electrospun fibers (2021-05-18),

14. 11007279 - Highly stable biodegradable gene vector platforms for overcoming biological barriers (2021-05-18),

15. 10933144 - Non-linear multiblock copolymer-drug conjugates for the delivery of active agents (2021-03-02),

As per the information provided, here is a detailed article about the accomplished inventor Justin Scot Hanes.

Title: Innovator Spotlight: Justin Scot Hanes - Pioneering Healthcare Solutions

Introduction:

Justin Scot Hanes is a renowned inventor based in Baltimore, MD, with an impressive portfolio of 68 patents to his name. His innovative approach to healthcare solutions has significantly impacted the field of medicine, particularly in the areas of treating bacterial vaginosis and enhancing particle transport in mucus.

Latest Patents:

1. CVS transplantation for the treatment of bacterial vaginosis: Justin's groundbreaking patent focuses on using cervicovaginal secretions (CVS) as a method for restoring beneficial vaginal microbial communities in women with bacterial vaginosis. By transplanting healthy CVS, the treatment aims to increase resistance to sexually transmitted diseases and improve disease resistance.

2. Nanocrystals, compositions, and methods for particle transport in mucus: Another key patent by Justin involves nanocrystals and compositions that aid in particle transport through mucus barriers in the body. These mucus-penetrating particles (MPP) offer a novel approach to drug delivery, imaging, and diagnostic applications, propelling advancements in pharmaceutical technology.

Career Highlights:

Justin Scot Hanes has made significant contributions during his tenure at prestigious institutions such as The Johns Hopkins University and the Massachusetts Institute of Technology. His expertise and dedication to innovative research have led to the development of transformative healthcare solutions with far-reaching implications.

Collaborations:

Throughout his career, Justin has collaborated with esteemed professionals in the field, including Laura M. Ensign and David A. Edwards. These partnerships have fostered a culture of innovation and knowledge exchange, leading to the successful implementation of groundbreaking ideas and technologies.

Conclusion:

In conclusion, Justin Scot Hanes stands as a visionary inventor whose contributions have revolutionized the healthcare industry. His pioneering work in treating bacterial vaginosis and advancing particle transport technology underscores his commitment to improving patient outcomes and pushing the boundaries of medical innovation.

Would you like to explore more inventors and their groundbreaking creations on our platform, idiyas.com?

Profile summary based on public USPTO records.